Your browser doesn't support javascript.
loading
Paeoniflorin inhibits macrophage-mediated lung cancer metastasis.
Wu, Qi; Chen, Gang-Ling; Li, Ya-Juan; Chen, Yang; Lin, Fang-Zhen.
Afiliación
  • Wu Q; State Key Laboratory of Natural Medicines, Research Department of Pharmacognosy, China Pharmaceutical University, Nanjing 211198, China.
  • Chen GL; Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China. Electronic address: chengangling@cpu.edu.cn.
  • Li YJ; Murad Research Institute for Modernized Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
  • Chen Y; Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
  • Lin FZ; Department of Pharmacology of Chinese Materia Medica, China Pharmaceutical University, Nanjing 211198, China.
Chin J Nat Med ; 13(12): 925-32, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26721711
Alternatively activated macrophages are more frequently involved in tumor growth, angiogenesis, and immunosuppression. A previous study showed that paeoniflorin, the major active constituent of Paeonia lactiflora Pallas, can inhibit tumor growth and lung metastases of Lewis lung tumor-bearing mice. This study tried to investigate whether paeoniflorin inhibited lung cancer metastasis by inhibiting the alternative activation of macrophages (M2 macrophage). Using a viability assay, the cytotoxicity of paeoniflorin on Lewis lung cancer cells and peritoneal macrophages were investigated. In vitro scratch wound and in vivo lung metastasis experiments were used to test the ability to inhibit the migration of paeoniflorin and the function of M2 macrophages. Flow cytometry was performed to test the cell cycle of Lewis lung cancer cells, and to test the M2 macrophages in peritoneal macrophages and subcutaneous transplantable tumor. It was found that paeoniflorin showed no inhibitory effect on the growth of Lewis lung cancer cells and peritoneal macrophages of mouse in vitro. Paeoniflorin could attenuate the migration of LLC stimulated by alternatively activated macrophages (stimulated for 24 h and 48 h, paeoniflorin 1, 3, 10, 30, 100 µmol·L(-1), P < 0.01 or P < 0.05 vs control group). Paeoniflorin could decrease the cell populations at S phases (paeoniflorin 10, 30, 100 µmol·L(-1), P < 0.05 vs control group) and increase the cell populations at G0-G1 phases of Lewis lung cancer cells (paeoniflorin 100 µmol·L(-1), P < 0.05 vs control group) and reduce the numbers of M2 macrophages in peritoneal macrophages induced by IL-4 (paeoniflorin 1, 3, 10, 30, 100 µmol·L(-1), P < 0.01 vs Control group). Paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft and decrease the numbers of M2 macrophages in subcutaneous xenograft tumour in vivo (paeoniflorin 20, 40 mg·kg(-1), P < 0.01 vs control group). These results suggest that paeoniflorin could reduce lung metastasis of Lewis lung cancer cells xenograft partly through inhibiting the alternative activation of macrophages.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paeonia / Monoterpenos / Glucósidos / Neoplasias Pulmonares / Macrófagos Límite: Animals / Female / Humans Idioma: En Revista: Chin J Nat Med Año: 2015 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Paeonia / Monoterpenos / Glucósidos / Neoplasias Pulmonares / Macrófagos Límite: Animals / Female / Humans Idioma: En Revista: Chin J Nat Med Año: 2015 Tipo del documento: Article País de afiliación: China Pais de publicación: China